Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

A Study of Obexelimab in Patients With Systemic Lupus Erythematosus

ClinicalTrials.gov ID: NCT06559163

Public ClinicalTrials.gov record NCT06559163. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 10, 2026, 8:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Obexelimab in Patients With Systemic Lupus Erythematosus

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study aims to examine the efficacy and safety of obexelimab in participants with systemic lupus erythematosus (SLE).

Study identification

NCT ID
NCT06559163
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Zenas BioPharma (USA), LLC
Industry
Enrollment
190 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 16, 2024
Primary completion
Aug 31, 2026
Completion
Nov 30, 2026
Last update posted
Aug 17, 2026

2024 – 2026

United States locations

U.S. sites
32
U.S. states
16
U.S. cities
31
Facility City State ZIP Site status
Onyx Clinical Research Peoria Arizona 85381
Sierra Pacific Arthritis and Rheumatology Centers Fresno California 93710
California Research Institute Huntington Park California 90255
University of California, San Diego La Jolla California 92037
University of California, Los Angeles Los Angeles California 90024
Solace Clinical Research Tustin California 92780
Yale University New Haven Connecticut 06520
Clinical Research of West Florida, Inc Clearwater Florida 33765
Clinical Research of West Florida, Inc. Tampa Florida 33606
Emory University Atlanta Georgia 30322
AARA Clinical Research - Chicago Arthritis & Regenerative Medicine Chicago Illinois 60661
Orthoillinois Rockford Illinois 61114
Willow Rheumatology and Wellness Willowbrook Illinois 60527
Accurate Clinical Research Lake Charles Louisiana 70605
Axon Clinical Research Baltimore Maryland 21237
UMass Chan Medical School Worcester Massachusetts 01655
Henry Ford Hospital Detroit Michigan 48202
Juno DO, PC Lansing Michigan 48911
Revive Research Institute - Sterling Heights Sterling Heights Michigan 48313
Velocity Clinical Research St Louis Missouri 63131
Hospital for Special Surgery New York New York 10021
SUNY Upstate Medical University Syracuse New York 13210
DJL Clinical Research PLLC Charlotte North Carolina 28211
Cross Creek Medical Clinic Fayetteville North Carolina 28304
Onsite Clinical Solutions Salisbury North Carolina 28144
Oklahoma Medical Research Foundation Oklahoma City Oklahoma 73104-5005
Penn State - Hershey Medical Center Hershey Pennsylvania 17033
AARA Clinical Research - Rheumatology Specialty Center Willow Grove Pennsylvania 19090
Prolato Clinical Research Center (PCRC) Houston Texas 77054
Accurate Clinical Research Houston Texas 77089
Prime Clinical Research - Lewisville Lewisville Texas 75067
Prime Clinical Research - Mansfield Mansfield Texas 76063

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 78 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06559163, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 17, 2026 · Synced Sep 10, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06559163 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →